Skip to main content

Table 1 Study Population.

From: Expression profiling in canine osteosarcoma: identification of biomarkers and pathways associated with outcome

Unique ID DFI Age at Dx (yrs) Sex Breed Tumor Site Tumor
Subtype
Chemotherapy Received
184844 40 4.4 MC Greyhound L Prox Humerus Osteoblastic Doxorubicin
208911 60 8.0 FS Doberman L Prox Humerus Giant cell Carboplatin
173175 69 5.0 MC Rottweiler L Dist Femur Osteoblastic Cisplatin
223986 77 7.0 MC Greyhound L Dist Femur Osteoblastic Carboplatin
153599 90 9.0 FS Mix L Tibia Giant cell Cisplatin
222189 91 6.1 FS Greyhound L Prox Humerus Osteoblastic Doxo & Carbo
204714 94 8.0 FS Greyhound L Prox Tibia Giant Cell Doxorubicin
208756 95 10.2 FS Labrador Ret. L Dist Humerus Osteoblastic Cisplatin
146719 97 8.8 MC Mix R Dist Femur Fibroblastic Doxorubicin
212759 97 10.8 MC Golden Ret. L Prox Humerus Osteoblastic Doxorubicin
177466 307 7.6 FS Mix L Dist Radius Osteoblastic Cisplatin
188084 329 10.4 MC Rottweiler R Dist Radius PD Doxorubicin
190030 356 13.4 MC Mix L Dist Humerus Osteoblastic Doxorubicin
180223 384 11.5 FS Mix R Prox Femur Osteoblastic Cisplatin
208513 467 7.1 MC Greyhound L Prox Humerus Osteoblastic Doxorubicin
180119 619 10.4 FS Mix R Dist Femur Osteoblastic Cisplatin
193231 694 12.4 MC Mix L Dist Radius Osteoblastic Doxorubicin
174513 734 10.1 FS Malamute L Dist Radius Osteoblastic Doxo & Carbo
155214 787 8.7 MC Labrador Ret. R Tibia Osteoblastic Doxorubicin
168327 885 8.0 FS Golden Ret. L Dist Radius Osteoblastic Carboplatin
  1. DFI = disease-free interval, Dx = diagnosis, MC = castrated male, FS = spayed female, L = left, Dist = distal, Prox = proximal, R = right, PD = poorly-differentiated, "Doxo & Carbo" = Doxorubicin and Carboplatin combination therapy,